PUMAS
LIVE

Serial Number

90356449

Owner

PUMAS-AI INC.

Attorney

Devon E. White

First Use Date

Jul 15, 2017

Filing Date

Dec 3, 2020

Add to watchlist:

No watchlists yet
View on USPTO

PUMAS Trademark

Serial Number: 90356449 • Registration: 6490579

PUMAS is a trademark filed by PUMAS-AI INC. on December 3, 2020. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

PUMAS-AI INC. (3 trademarks)

3500 SOUTH DUPONT HIGHWAY
DOVER, DE 19901

Entity Type: 03

Trademark Details

Filing Date

December 3, 2020

Registration Date

September 21, 2021

First Use Anywhere

July 15, 2017

First Use in Commerce

June 19, 2019

Published for Opposition

July 6, 2021

Goods & Services

downloadable computer software that uses artificial intelligence for managing, accessing and sharing information and data in the fields of performance metrics, data visualizations, and predictive analytics in the healthcare and life sciences industries; downloadable computer software that uses artificial intelligence for conducting mathematical and statistical modeling and simulation of drug effects for third party pharmaceuticals, diagnostic, and health care products; software featuring machine learning and artificial intelligence for data analysis in the fields of data processing, analytics, information processing, data analysis, artificial intelligence, machine learning, deep learning, compound property prediction, compound structure prediction and data visualization in the fields of chemistry, pharmaceutical and agrochemical research and development; downloadable computer software for use in the pharmaceutical industry for drug discovery and design, clinical trial design, and data analysis for guiding experiment and study related decisions, namely, dose selection, patient selection, risk factor identification, endpoint selection, and for identifying genomic markers for efficacy and safety in support of regulatory submission to support product registration; downloadable computer artificial intelligence software for use in the pharmaceutical industry for drug discovery and design, clinical trial design, and data analysis; downloadable computer software for use in biological and chemical research, development, validation and testing in the life sciences field, including primarily the fields of biology, genomics, proteomics and pharmaceuticals for characterizing mechanism of action, understanding systems level biology and pharmacology, guide dose selection, and identify predictors for efficacy and safety; downloadable software platform using machine learning and artificial intelligence for training deep learning models on medical data and for use in medical predictions for use by healthcare organizations, life science and pharmaceutical companies to enhance precision in care quality, improve patient experience and advance new drugs and treatment methods, namely, building translational models, identifying patterns unknown to biology, augmenting systems biology models, enabling quality-by-design for pharmaceutical manufacturing, guiding treatment trajectory, precision dosing, individualized therapy, and extraction of signal from imaging data; downloadable bioinformatics software for use in healthcare information management and analysis, namely, for capturing, storing, aggregating, viewing, and analyzing medical data, medical test results, diagnostic data, slides and specimens, in the fields of healthcare, medical research and clinical research; downloadable software for use in healthcare information management and analysis, namely, for capturing, storing, aggregating, viewing, and analyzing medical data, medical test results, diagnostic data, slides and specimens, in the fields of healthcare, medical research and clinical research; downloadable medical data monitoring, and applications that record, monitor, and analyze medical data, patient data, and provide patient diagnosis risk assessment for identifying trends related to patient treatment

providing business intelligence services in the fields of medical devices, pharmaceuticals and the life sciences

research and development in the field of artificial intelligence software for managing, accessing and sharing information and data in the fields of performance metrics, data visualizations, and predictive analytics in the healthcare and life sciences industries; scientific advisory services in the nature of computer modeling services, namely, computer simulation from computer programs for conducting mathematical and statistical modeling and simulation of drug effects for third party pharmaceuticals, diagnostic, and health care products; design and development of computer software for use in pharmaceutical research and development; scientific research, namely, research and analysis services in the scientific fields of artificial intelligence and machine learning analytics; research and analysis services in the fields of biology, biotechnology, bioinformatics and in the pharmaceutical field; scientific research, namely, providing data analytics and data modelling to others in the fields of medical and pharmaceutical research and development; providing temporary use of web-based software featuring predictive analytics in the healthcare and life sciences industries; providing temporary use of web-based software for managing, accessing, analyzing, and sharing information and data in the healthcare and life sciences industries, namely, information and data in the fields of real world evidence

Filing History

NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
Apr 8, 2025 NURC
NEW CERTIFICATE UNDER SECTION 7 - PROCESSED
Mar 15, 2025 C.7C
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 10, 2025 APRE
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Oct 16, 2024 ASGN
TEAS SECTION 7 REQUEST RECEIVED
Oct 10, 2024 ES7R
REGISTERED-PRINCIPAL REGISTER
Sep 21, 2021 R.PR
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 6, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 6, 2021 TCCA
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 6, 2021 COAR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 6, 2021 NPUB
PUBLISHED FOR OPPOSITION
Jul 6, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 16, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 3, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 2, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 2, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 2, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 21, 2021 GNRN
NON-FINAL ACTION E-MAILED
May 21, 2021 GNRT
NON-FINAL ACTION WRITTEN
May 21, 2021 CNRT
ASSIGNED TO EXAMINER
May 21, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 8, 2021 NWOS
NEW APPLICATION ENTERED
Dec 7, 2020 NWAP